Title

Raymond A. Dionne D.D.S., Ph.D Joins Charleston Laboratories, Inc Scientific Advisory Board

Gary A. Peltz, M.D. Joins Charleston Laboratories, Inc Scientific Advisory Board

Charleston Laboratories, Inc submitted a request with the U.S. Food and Drug Administration (FDA) for a Pre-Investigational New Drug (Pre-IND) meeting regarding the development of CL-H1T.

Robert H. Dworkin, Ph.D Joins Charleston Laboratories, Inc Scientific Advisory Board

31st Annual J.P. Morgan Healthcare Conference

Charleston Laboratories, Inc. Appoints Ryan Baker Executive Vice President and Chief Operating Officer

Download PDF

Charleston Laboratories, Inc. Appoints Bill Kozarek Ph.D Vice President of Product Development

Download PDF

30th Annual J.P. Morgan Healthcare Conference

BIO International Convention 2009

Charleston Completes Preliminary Research on Nausea-Prone Questionnaire (NPQ)

Download PDF

27th Annual J.P. Morgan Healthcare Conference

Charleston Labs begins Bioequivalence Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CL-108

Download PDF

Charleston Sucessfully Completes Series A Private Placement

Download PDF

Charleston Laboratories, Inc. Investigational New Drug CL-108 “Safe to Proceed Testing in Man.”

Download PDF

26th Annual J.P. Morgan Healthcare Conference

Charleston Laboratories, Inc. Appoints John F. Ameling V.P of Regulatory Affairs

Download PDF

Charleston Laboratories, Inc. Appoints Bernard Schachtel, M.D. Chief Medical Officer

Download PDF